Light & photobiomodulation · graded by use, three uses
Infrared Sauna
Graded on: cardiovascular / endothelial (surrogate + functional).
Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →
Compare this record with another, side by side →
How this letter has changedLatest: October 2026 · Downgraded.
The heart failure use rests on one trial, WAON-CHF (Tei et al., Circ J, 2016; PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 27001189), whose primary endpoint The one outcome a trial names in advance as its main test. Results on other outcomes carry less weight. was null. The vascular use rests on a small marker trial (Masuda et al., 2004; PMID 15090706) against a null crossover A trial design in which each participant receives both the treatment and the comparison, one after the other, and serves as their own control. (Hussain et al., 2022; PMID 34954348); a coronary disease trial was also null on vascular measures (Debray et al., 2023; PMID 37650138). A single unrepeated trial is C, and an oxidative-stress marker is not an established stand-in. Applied the written grade definition: the B definition admits a biomarker A measurable sign in the body, such as a blood test value, used to track a condition or the effect of a treatment. only when it is an established stand-in for a clinical outcome, such as HbA1c A blood test that reflects average blood sugar over the previous two to three months., LDL Low-density lipoprotein cholesterol, the cholesterol fraction most closely tied to plaque in the arteries., blood pressure or bone density, the strict reading the editor confirmed in October 2026.PMID 15090706 PMID 27001189 PMID 34954348 PMID 37650138
Every change to a letter on this site is dated and published. The full evidence log →
Infrared saunas warm the body with infrared light rather than hot air. In one study of people with heart failure, sauna sessions did not change the main heart blood test the study set out to measure. People did walk farther and reported feeling better. Small studies of blood markers gave mixed results. Reports from Finland link sauna use to longer life, but they only show a link.
The C is shared by two of the three uses graded on this record, each on its own evidence. The other one carries its own letter.
As studied, and the trials
Tei et al. (Circ J, 2016; PMID 27001189), WAON-CHF: 149 hospitalized patients with advanced heart failure, 10 days of Waon therapy or control. The primary endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score., B-type natriuretic peptide, did not differ significantly; NYHA class, six-minute walk distance and cardiothoracic ratio improved. One trial, its primary endpoint null, not repeated by an independent group: C.
As studied, and the trials
Masuda et al. (Jpn Heart J, 2004; PMID 15090706): 28 patients with coronary risk factors, 2 weeks; a urinary oxidative-stress marker and systolic pressure fell. Hussain et al. (Complement Ther Med, 2022; PMID 34954348): a single-session crossover in 10 women, no change in blood pressure or arterial stiffness. An oxidative-stress marker is not an established stand-in for a clinical outcome, and the evidence is one small positive trial against a null one: C.
As studied, and the trials
Read the grade that matches your goal. How EBL grades by use →
Thermal therapy · Cardiovascular
A letter describes the human evidence, not the product, the manufacturer, or the intervention's worth.
Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Grade C. The heart failure use rests on one multicenter trial, WAON-CHF (Tei et al., Circ J, 2016; PMID 27001189), whose primary endpoint, B-type natriuretic peptide, did not differ; functional class and walk distance improved as secondary outcomes. The vascular use rests on a 28-person, 2-week trial on a urinary oxidative-stress marker (Masuda et al., 2004; PMID 15090706) against a null single-session crossover (Hussain et al., 2022; PMID 34954348). Neither meets the B definition.
WHAT THIS GRADE DOES NOT COVERmortality, where the Finnish sauna data are observational Research that watches what people already do rather than assigning a treatment. It can show that two things travel together, not that one causes the other. and carry no letter.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Regular sauna bathing has human RCT Randomized controlled trial: people are assigned to the treatment or a comparison by chance, so the groups differ only in what they received. It is the design that can show cause and effect. evidence for blood pressure reduction, arterial stiffness improvement, and inflammatory marker reduction. Finnish cohort data from 2,315 men over 20 years associates sauna use 4 to 7 times per week with a 50 percent reduction in cardiovascular mortality and 40 percent reduction in all-cause mortality compared to once weekly. Grade C: the vascular evidence rests on one small marker trial against two null trials, and the one heart failure trial did not meet its primary endpoint, BNP. The cohort data cannot establish causation and do not carry the grade.
| Types | Traditional Finnish sauna (80-100°C, high humidity). Far-infrared sauna (45-60°C, penetrates tissue directly). Near-infrared. Most human RCT evidence is from traditional Finnish sauna. Infrared sauna has separate but consistent supporting evidence. |
| Protocol (RCT-based) | 3 to 4 sessions per week, 15 to 30 minutes per session at 73°C / 163°F or higher. The Finnish cohort data used traditional sauna. Re-entering before body temperature has normalized adds to the heat load. |
| Contraindications A condition or medication that makes a treatment unsafe or unsuitable for a particular person. | Acute illness, fever, unstable angina, recent MI (within 1 month), severe aortic stenosis. Pregnancy, hypotension and active alcohol use call for caution. |
| Cost | Commercial sauna membership: $30 to $100/month. Home traditional sauna: $2,000 to $8,000. Home infrared sauna: $1,500 to $5,000. Sauna blankets: $200 to $600 (less evidence). |
| Hydration | A 30-minute sauna session can cause 0.5 to 1 L fluid loss. Water before and after replaces that loss. Alcohol before sauna adds to the heat-illness risk. |
| Post-sauna | The cool-down is gradual. Cold shower optional. The Scandinavian hot-cold contrast protocol has additional evidence for vascular adaptation but is a separate intervention. |
Blood pressure before and after sessions to confirm cardiovascular response. hs-CRP High-sensitivity C-reactive protein, a blood marker of low-grade inflammation. for inflammation trend over months. Resting heart rate trend. Subjective recovery and sleep quality. The cohort mortality data are associated with 3 to 4 sessions per week.
20-year follow-up of 2,315 Finnish men using traditional Finnish saunas, not infrared cabins. Bathing 4 to 7 times per week was associated with a 63 percent lower risk of sudden cardiac death than once a week (hazard ratio How often an event happened in the treated group compared with the control group over the same period. A ratio of 0.80 means 20 percent fewer events. 0.37), with similar associations for coronary, cardiovascular and all-cause mortality. Observational data only.
This study does not carry the grade and never did. EBL grades only published human randomized trials, and this is a prospective cohort. It is shown because it is the best-known evidence on sauna and longevity and you will meet it elsewhere. It is excluded because Finnish men who use a sauna four to seven times a week differ from men who do not in ways no statistical adjustment fully removes. The grade rests on the randomized trials of surrogate and functional endpoints listed above, not on this.
25 men with at least one coronary risk factor used a 60°C far-infrared sauna for 15 minutes, then rested under blankets for 30 minutes, once a day for two weeks. Flow-mediated dilation, a measure of blood vessel lining function, rose from 4.0 to 5.8 percent. There was no randomized comparison group: 10 healthy men were measured once for reference. A surrogate measure in a small uncontrolled study.
16 patients with untreated hypertension went through a control period, sauna alone, and exercise followed by sauna, in random order. Exercise followed by sauna lowered 24-hour systolic and mean blood pressure; sauna alone and with exercise lowered vascular resistance for up to 2 hours. A traditional sauna, single sessions, a small sample.
Most serious risks are dehydration and heat illness. Fluid loss in a single session can be substantial, and dehydration is the mechanism behind most reported harm. Intoxication and sauna together raise that risk further. People with cardiovascular conditions should start with shorter sessions (10-15 min) at lower temperatures and consult their physician. Contraindicated in pregnancy, unstable cardiac conditions, and recent surgical wounds.
Antihypertensives: sauna lowers blood pressure; combination with antihypertensive medication can cause hypotension. Diuretics increase dehydration risk in sauna. Alcohol: dramatically increases cardiovascular risk in sauna. The two together add to the risk.
Sauna is one of the most evidence-supported passive longevity interventions on the platform. The cardiovascular effect size How large a difference the treatment made, as distinct from whether the difference could be detected at all. in the Finnish cohort data is larger than most active pharmaceutical interventions for cardiovascular risk. The mechanism is plausible: repeated thermal stress produces similar cardiovascular adaptations to moderate aerobic exercise, including improved endothelial function, arterial compliance, and autonomic tone.
Educational use only · Not medical advice · Starting, stopping or changing any supplement or medication is a decision for your physician
EBL does not verify the regulatory status of any device. Many consumer wellness devices are not FDA-cleared The FDA found a device substantially equivalent to one already on the market. Clearance is not approval and does not require trials showing benefit., and FDA clearance, where it exists, applies only to specific indications. The grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Using any device for a health purpose is a decision for your physician.
Primary evidenceFour papers, each linked to its PubMed record.
Tei et al. (Circulation Journal, 2016; PMID 27001189, Waon therapy), Masuda et al. (Japanese Heart Journal, 2004; PMID 15090706), Hussain et al. (Complementary Therapies in Medicine, 2022; PMID 34954348) and Schenaarts et al. (2024; PMID 39209309): randomized trials of sauna/Waon therapy. Grade C: one heart failure trial whose primary endpoint was null, and marker trials that are small and mixed.
Products carry no letter. The letter belongs to the therapy as the trials studied it, and no trial tested these products unless the entry says so. Listed alphabetically; payment does not affect order.
Portable far-infrared sauna. No trial has tested this product; the Infrared Sauna grade describes the modality as studied.
Portable far-infrared unit used at home without supervision. The graded trials used a supervised clinical sauna protocol in people with heart failure, a different population and setting.
Home infrared saunas, including models that add red light panels. The company makes general wellness claims and no disease claims were found. No trial has tested this brand; the Infrared Sauna grade describes the modality as studied.
Home cabin sauna. The graded trials used supervised Waon-style dry sauna at about 60 C for 15 minutes; a home cabin run at other temperatures and durations is not the protocol those trials tested.
Far-infrared panels with low-EMF technology. More accessible price point. Good for home installation with standard electrical. Consumer-focused design.
Portable far-infrared sauna blanket that heats up to 175°F, per the manufacturer. Lower whole-body heat load than a full cabin.
Full-spectrum (near + mid + far) infrared. The most clinically studied brand in longevity literature. Chromotherapy included. Evidence base strongest for cardiovascular and recovery protocols.
Not matched to the studied protocol. The heart failure trial behind the C used a far-infrared dry sauna held at 60 degrees C for 15 minutes, followed by 30 minutes of bed rest under a blanket, once daily for 10 days, in hospitalized patients with advanced heart failure. EBL has not verified this cabin's heater spectrum, temperature or session settings against that protocol, and no trial behind the grade tested this model.
This page carries a letter. EBL takes no commission, referral fee or payment of any kind on anything it grades. No letter has been bought and none is for sale. Products listed under this modality may be commercial partners, and their purchase links may earn EBL a commission. Those products carry no letter of their own, every relationship is disclosed beside the link, and where a product does not deliver what the trials tested, this page says so regardless of who pays.
How this is enforced
That is not a promise, it is a build condition. Two checks run on every deploy: one refuses to publish if a commission is claimed on anything graded, the other refuses if a page names a commercial relationship that is not declared in the register. If either fails, this page does not go live. You can read how the checks work, and what they do not cover, on the evidence integrity page.
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
(sauna[tiab] OR "Waon therapy"[tiab] OR "thermal therapy"[tiab]) AND randomized controlled trial[pt]Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →